January 13, 2021

MEET THE EXPERTS: JOE FARAGO

Joe Farago is Executive Director, Private Payers and Investment at Innovative Medicines Canada (IMC). Joe leads IMC’s efforts to take a more proactive, research-based approach to ensuring tomorrow’s workforce has […]

January 13, 2021

New IMC report shows impact of chronic disease and increased claims on private drug plans

Growth in chronic disease and increased drug claims […]

December 30, 2020

Delaying implementation of PMPRB’s Regulations an opportunity to protect patient access to medicines and vaccines

We support Health Canada’s decision to delay […]

December 29, 2020

IMC says there is still time for the federal government to put Canadian patients first by delaying the January 1, 2021 implementation of PMPRB’s Regulations and Guidelines

Ottawa, December 29, 2020 – Innovative Medicines Canada (IMC) issued the following statement today regarding the looming implementation of the Patented Medicines Prices Review Board’s (PMPRB’s) Final Regulations and Guidelines, […]

December 21, 2020

Still time for federal government to act to protect patient access to new medicines and vaccines before January 1, 2021 implementation of new PMPRB Regulations and Guidelines

Ottawa, December 21, 2020—Innovative Medicines Canada (IMC) issued the following statement today warning of the impact the Patented Medicines Prices Review Board’s (PMPRB’s) Final Regulations and Guidelines will have on […]